FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely, it is aimed at treating or preventing coronavirus infection in humans or animals caused by the SARS-Cov-2 virus by using a compound of general formula 1, where R is CH3, or its hydrochloride salt, dihydrochloride salt or hexahydrate dihydrochloride.
EFFECT: high antiviral activity against coronavirus infection in humans or animals caused by the SARS-Cov-2 virus.
   1
        1
4 cl, 6 tbl, 9 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| 4,6-DI(3,12-DIAZA-6,9-DIAZONIADISPIRO[5,2,5,2]HEXADECAN-1-YL)-2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE HYDROCHLORIDE HEXAHYDARATE FOR TREATING HERPETIC INFECTION, PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION | 2014 | 
 | RU2573977C9 | 
| PYRIMIDYL-DI(DIAZADISPIROALKANE)S WITH ANTIVIRAL ACTIVITY | 2015 | 
 | RU2633699C2 | 
| INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 | 
 | RU2820633C1 | 
| MEFLOQUINE AND COMBINATIONS THEREOF FOR TREATING AND PREVENTING A CORONAVIRUS INFECTION | 2020 | 
 | RU2763024C1 | 
| METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION | 2020 | 
 | RU2747467C1 | 
| AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 | 
 | RU2788762C1 | 
| OBTAINING A WATER-SOLUBLE 6-BROMO-1-METHYL-5-METHOXY-2-(1-PIPERIDINOMETHYL)-3-(2-DIETHYLAMINOETHOXY) CARBONYLINDOLE DIHYDROCHLORIDE COMPOUND | 2024 | 
 | RU2835077C1 | 
| METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 | 
 | RU2794315C1 | 
| AGENT FOR REDUCING RISK AND RELIEVING SYMPTOMS OF BETA-CORONAVIRUS INFECTION | 2021 | 
 | RU2747890C1 | 
| ETHYL ESTER OF 2-(ADAMANTAN-1-yl)-3-BROMO-7-OXO-4,7-DIHYDROPYRAZOLO[1,5-a]PYRIMIDINE-6-CARBOXYLIC ACID, HAVING ANTIVIRAL ACTION ON SARS-CoV-2 CORONAVIRUS | 2024 | 
 | RU2839407C1 | 
Authors
Dates
2021-12-14—Published
2020-12-08—Filed